Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
Clinical trial NCT02730377 · COMPLETED
Trial details
- NCT number
- NCT02730377
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-28
- Primary completion
- 2019-08-05
- Enrollment
- 1991
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.